Skip to content

Norepinephrine infusion for controlling spinal anaesthesia induced hypotension in caesarian section.

Effect of different doses of norepinephrine infusion for controlling spinal anaesthesia induced hypotension in caesarean section- a randomized controlled study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056943
Enrollment
120
Registered
2023-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Administration of intravenous infusion of 5 micrograms/kg/hr or 8 micrograms/kg/hr or10 micrograms/kg/hr of Norepinephrine: Study participants will be randomized into 4 groups. Interven

Sponsors

Anish M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age group 18 to 50 years undergoing elective caesarean section 2.Patients with ASA physical grade I or II

Exclusion criteria

Exclusion criteria: 1. History of allergy to local anaesthetic agent and/ or study drugs 2. Bleeding disorders like Von Willebrand disease, ITP, platelet count 14 seconds, International normalised ratio (INR) > 1.5 3. Local site infection 4. Spinal deformity 5. Cardiac, respiratory diseases and kidney disorder, neurological deficit 6. Parturients with PET or any hypertensive disorder.

Design outcomes

Primary

MeasureTime frame
Occurrence of hypotensionTimepoint: Outcome will be continuously recorded every 2 mins till 10 mins then every 5 mins until the end of surgery & data will be asessed at the end of 1 year

Secondary

MeasureTime frame
Apgar score, umbilical vein blood gases record , Hemodynamic changes, norepinephrine consumption, adverse effects Timepoint: All outcomes will be continuously recorded every 2 mins till 10 mins & then every 5 mins until the end of surgery

Countries

India

Contacts

Public ContactDr T Hemjit Singh

Regional Institute of Medical Sciences , Imphal

takhelhem@yahoo.com9436021445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026